| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/01/2007 | CN1329082C Polymer conjugates of interferon beta-1a and their uses |
| 08/01/2007 | CN1329080C Cachexia remedy |
| 08/01/2007 | CN101010432A Disarmed agrobacterium strains, Ri-plasmids, and methods of transformation based thereon |
| 08/01/2007 | CN101010430A RAGE fusion proteins and methods of use |
| 08/01/2007 | CN101010341A Vaccine composition comprising a class ii cmh ligand coupledwith an antigen, method for the preparation and the use thereof |
| 08/01/2007 | CN101010340A Glp-1 and exendin related invention |
| 08/01/2007 | CN101010339A Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions |
| 08/01/2007 | CN101010338A Muteins of fibroblast growth factor 21 |
| 08/01/2007 | CN101010337A Fas associated factor 1 |
| 08/01/2007 | CN101010335A Methods and compositions for the treatment of gastrointestinal disorders |
| 08/01/2007 | CN101010333A Purification of factor xiii polypeptides from biological materials |
| 08/01/2007 | CN101010097A Hai-1 and hai-2 in cancer therapy |
| 08/01/2007 | CN101008012A Novel human-derived neurotrophic factor BDNF expression structure and its expression |
| 08/01/2007 | CN101007852A Natural antibacterial agent-recombinant chicken-beta defensins Gal-9-Gal-8 double-molecule protein preparation method |
| 08/01/2007 | CN101007848A Long chain human insulin-like growth factor(LR3IGF-1) and its preparing process and application method |
| 08/01/2007 | CN101007847A Human horny cell growth factor-2 mutant and its preparation method |
| 08/01/2007 | CN101007846A T8 synthetic product and application thereof |
| 08/01/2007 | CN101007845A Method for screening high egg-yield fowl |
| 08/01/2007 | CN101007842A T4 synthetic product and application thereof |
| 08/01/2007 | CN101007173A Anti-angiogene compositions and methods of use |
| 08/01/2007 | CN101007027A Application method of neural regulation protein in the treatment of cardiovascular diseases and its composition |
| 07/31/2007 | US7250560 Isolated nucleic acid molecule encoding Na+/H+ exchanger polypeptides for extrusion of monovalent cations from the cytosol of cells to provide the cell with increased salt tolerance |
| 07/31/2007 | US7250558 Disease resistance factors |
| 07/31/2007 | US7250557 Plastidic phosphoglucomutase genes |
| 07/31/2007 | US7250556 Transposable elements in rice and methods of use |
| 07/31/2007 | US7250555 Methods for enhancing a plant stress response |
| 07/31/2007 | US7250554 Precise breeding |
| 07/31/2007 | US7250553 System for functional gene discovery in plants |
| 07/31/2007 | US7250507 Inhibitory Pellino nucleic acids |
| 07/31/2007 | US7250505 Polynucleotide that encodes the Drosophila murine Dab 1 (Disabled protein 1); improve the development of the nervous system; protein phosphotyrosine levels; Antibodies for drug screening and diagnostic methods |
| 07/31/2007 | US7250503 Nucleic acid molecules encoding clot-specific streptokinase fusion proteins possessing altered plasminogen activation characteristics |
| 07/31/2007 | US7250501 Bacillus crystal protein having improved insecticidal activity; transgenic plant; polynucleotide segment having a sequence region that encodes an insecticidal hybrid delta-endotoxin protein |
| 07/31/2007 | US7250500 Nematode PAN and ZP receptor-like sequences |
| 07/31/2007 | US7250498 Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer |
| 07/31/2007 | US7250495 PRO20044 polypeptides |
| 07/31/2007 | US7250493 FC fusion proteins of human erythropoietin with increased biological activities |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250491 Hemolytic active proteins and genes encoding the same |
| 07/31/2007 | US7250489 Detecting nut allergy |
| 07/31/2007 | US7250488 Transcriptional activation inhibitory protein |
| 07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
| 07/31/2007 | US7250406 Compositions and methods for the acceleration of protein secretion dynamics |
| 07/31/2007 | US7250405 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 07/31/2007 | US7250404 Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response |
| 07/31/2007 | US7250400 Can be used for developing a study of cell attachment activity mediated through various extracellular matrix protein containing beta ig-h3, wound healing, tissue regeneration and metastasis inhibition. |
| 07/31/2007 | US7250398 Useful as animal feed additives, particularly further containing phytase, xylanase, galactanase, and/or beta-glucanase |
| 07/31/2007 | US7250395 Antagonist peptides to VEGF receptor Flt-1 |
| 07/31/2007 | US7250298 Monomeric red fluorescent proteins |
| 07/31/2007 | US7250297 Production of proteins exhibiting bonding activity for anticalins; peptides of the lipocalin family are modified by amino acid replacement in their natural ligand binding pocket using genetic engineering |
| 07/31/2007 | US7250296 Nucleotide sequences of 2S albumin gene and its promoter from grape and uses thereof |
| 07/31/2007 | US7250295 Fungal vomitoxin mimetic for detection and treating fungal infections in animals or humans; immunoassay |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250276 Used to study cellular processes such as immune regulation, cell proliferation, cell death, and inflammatory responses |
| 07/31/2007 | US7250275 LIF has a differentiation prevention function for a chicken differentiable cell such as a chicken's embryonic stem cell or embryonic reproductive cell, effective as an anti-differentiator while the chicken differentiable cell is being cultured |
| 07/31/2007 | US7250274 IL-21 production in prokaryotic hosts |
| 07/31/2007 | US7250273 Human peroxisome proliferator activated receptor γ: compositions and methods |
| 07/31/2007 | US7250272 Signal transduction membrane protein for diagnosis, prevention and treatment of central nervous system, endocrine, metabolic and cancer |
| 07/31/2007 | US7250264 Administering to host a therapeutically effective amount of an agent which prevents the interaction of mucosal addressin cell adhesion molecule-1 with a ligand therefor |
| 07/31/2007 | US7250263 Methods and compositions for identifying receptor effectors |
| 07/31/2007 | US7250261 For therapy and diagnosis of Escherichia coli infections |
| 07/31/2007 | US7250251 For detection of infection of a target cell by an enveloped retroviral virion human immunodeficiency virus (HIV); chimeras; kits |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250172 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 07/31/2007 | US7250170 Optimized expression of HPV 45 L1 in yeast |
| 07/31/2007 | US7250169 Anti-tumor activity of Ea-4-peptide of pro-IGF-1 |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | US7250163 Preparing immunoglobulins specific to galanin binding protein for use in treatment and prevention of nervous system disorders |
| 07/31/2007 | US7250161 Equine GM-CSF |
| 07/31/2007 | CA2331936C Proteins with changed epitopes and methods for the production thereof |
| 07/31/2007 | CA2284863C Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 07/31/2007 | CA2100745C Amylin agonist peptides and uses therefor |
| 07/31/2007 | CA2085469C Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 07/31/2007 | CA1341537C Production of pluripotent granulocyte colony-stimulating factor |
| 07/26/2007 | WO2007084985A1 Composition and method to increase mammalian sperm function |
| 07/26/2007 | WO2007084740A2 Tat-030 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084708A2 Tat-028 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084631A2 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 07/26/2007 | WO2007084583A2 Soluble fragments of the sars-cov spike glycoprotein |
| 07/26/2007 | WO2007084531A2 A novel binding site for retigabine on kcnq5 |
| 07/26/2007 | WO2007084527A2 Proteins containing a fluorinated amino acid, and methods of using same |
| 07/26/2007 | WO2007084497A1 A novel rat voltage-gated potassium channel |
| 07/26/2007 | WO2007084441A2 Novel fsh glycosylation variant d3n |
| 07/26/2007 | WO2007084388A2 Nogo-b receptor |
| 07/26/2007 | WO2007084364A2 Improved il-12 for expression in mammalian cells |
| 07/26/2007 | WO2007084342A2 Codon optimi zed il- 15 and il- 15r-alpha genes for expression in mammalian cells |
| 07/26/2007 | WO2007084133A1 Crystal structure of a bacterial homologue of na(+) cl(-)-dependent neurotransmitter transporters |
| 07/26/2007 | WO2007084053A1 A NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE) |
| 07/26/2007 | WO2007084021A2 Compositions and methods for diagnosing hiv-2 infection |
| 07/26/2007 | WO2007083949A1 Pharmaceutical composition for treating vascular-related diseases comprising peptide |
| 07/26/2007 | WO2007083853A1 Novel peptide and use thereof |
| 07/26/2007 | WO2007083683A1 Method of removing sialic acid and process for producing asialoerythropoietin |
| 07/26/2007 | WO2007083246A2 Vegf variants |
| 07/26/2007 | WO2007083175A1 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 07/26/2007 | WO2007083094A1 Prevention/treatment of ichthyosis vulgaris, atopy and other disorders |
| 07/26/2007 | WO2007082980A1 Compositions and methods for treating inflammatory, immune disorders with cortistatin |
| 07/26/2007 | WO2007082973A1 Use of a polypeptide that comprises the c-terminal domain of the heavy chain of tetanus toxin in the treatment of parkinsonism |
| 07/26/2007 | WO2007082777A1 C-terminal exon 5.4 of runx1/aml1 |
| 07/26/2007 | WO2007082483A1 Medicament for treatment of tumor and the use thereof |
| 07/26/2007 | WO2007082359A1 Luciferase from macrolampis sp |